|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.70 BDT | 0.00% |
|
-0.35% | +4.74% |
| Market Cap | 6.69B 54.15M 46.9M 43.72M 40.21M 75.9M 5.15B 76.75M 514M 202M 2.58B 203M 199M 8.53B | P/E 2024 |
50.8x | P/E 2025 | -17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 32.23B 261M 226M 211M 194M 366M 24.8B 370M 2.47B 971M 12.41B 979M 958M 41.09B | EV / Sales 2024 |
3.62x | EV / Sales 2025 | 7.99x |
| Free-Float |
74.17% | Yield 2024 |
1.45% | Yield 2025 | - |
| 1 week | -0.35% | ||
| Current month | +0.35% | ||
| 1 month | +0.70% | ||
| 3 months | +7.89% | ||
| 6 months | +3.99% | ||
| Current year | +4.74% |
| 1 week | 28.6 |  | 29.2 |
| 1 month | 28.2 | | 31.1 |
| Current year | 25.1 | | 32.6 |
| 1 year | 22.9 | | 42.9 |
| 3 years | 22.9 | | 91.8 |
| 5 years | 22.9 | | 156.5 |
| 10 years | 22.9 | | 156.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zareen Karim
CEO | Chief Executive Officer | 48 | 2019-12-31 |
| Director of Finance/CFO | - | - | |
| Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2014-09-09 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 1984-12-31 |
Hasina Begum
BRD | Director/Board Member | 68 | 1996-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.35% | -10.03% | -63.94% | 54.33M | |
| +4.86% | -3.32% | +52.73% | +160.26% | 1,043B | |
| +1.04% | -2.99% | +50.87% | +52.38% | 621B | |
| +0.98% | -6.49% | +24.00% | +66.66% | 435B | |
| +0.26% | +3.76% | +47.51% | +38.46% | 361B | |
| +0.79% | -0.96% | +35.93% | +39.74% | 293B | |
| +0.17% | -5.24% | +9.05% | +10.73% | 251B | |
| +4.57% | +5.21% | +35.91% | +67.64% | 220B | |
| +1.77% | -9.76% | +3.14% | -45.28% | 201B | |
| -2.58% | -0.73% | +17.16% | +67.46% | 164B | |
| Average | +0.76% | -3.46% | +26.63% | +39.41% | 358.92B | |
| Weighted average by Cap. | +0.85% | -3.79% | +38.54% | +76.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.62B 85.93M 74.42M 69.38M 63.81M 120M 8.17B 122M 815M 320M 4.09B 323M 316M 13.54B | 4.08B 33.02M 28.6M 26.66M 24.52M 46.3M 3.14B 46.81M 313M 123M 1.57B 124M 121M 5.2B |
| Net income | 318M 2.57M 2.23M 2.08M 1.91M 3.61M 245M 3.65M 24.42M 9.58M 122M 9.67M 9.45M 406M | -415M -3.36M -2.91M -2.71M -2.49M -4.71M -319M -4.76M -31.88M -12.51M -160M -12.62M -12.34M -529M |
| Net Debt | 22.31B 180M 156M 146M 134M 253M 17.16B 256M 1.71B 672M 8.59B 678M 663M 28.44B | 25.54B 207M 179M 167M 153M 290M 19.65B 293M 1.96B 769M 9.83B 776M 759M 32.56B |
Employees
2,954
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | BDT 28.70 | 0.00% | 175,115 |
| 26-08-03 | BDT 28.70 | -0.35% | 344,643 |
| 26-08-02 | BDT 28.80 | +0.70% | 263,371 |
| 26-07-30 | BDT 28.60 | -0.69% | 202,171 |
| 26-07-29 | BDT 28.80 | -2.04% | 348,257 |
- Stock Market
- Stocks
- ORIONPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
